Search research articles
Contact Us
Filters
Showing results (251-260 of 265) with videos related to
Page
of 27
Sort By:
Neurology
|
August 28, 2019
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function
Eric P Hoffman, Benjamin D Schwartz, Laurel J Mengle-Gaw, et al.
Journal of Neuroimmunology
|
April 13, 2010
Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis
K C O'Connor, C Lopez-Amaya, D Gagne, et al.
Journal of Comparative Effectiveness Research
|
August 28, 2020
Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy
Craig Campbell, Richard J Barohn, Enrico Bertini, et al.
Pharmacological Research
|
September 17, 2018
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug
Laurie S Conklin, Jesse M Damsker, Eric P Hoffman, et al.
The Lancet. Neurology
|
April 5, 2011
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study
Brenda Banwell, Amit Bar-Or, Douglas L Arnold, et al.
American Journal of Human Genetics
|
February 2, 2022
Bi-allelic variants in neuronal cell adhesion molecule cause a neurodevelopmental disorder characterized by developmental delay, hypotonia, neuropathy/spasticity
Alina Kurolap, Florian Kreuder, Claudia Gonzaga-Jauregui, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
June 5, 2020
A National Spinal Muscular Atrophy Registry for Real-World Evidence
Victoria L Hodgkinson, Maryam Oskoui, Joshua Lounsberry, et al.
Contemporary Clinical Trials
|
April 29, 2017
Developing standardized corticosteroid treatment for Duchenne muscular dystrophy
Michela Guglieri, Kate Bushby, Michael P McDermott, et al.
Acta Neuropathologica
|
August 30, 2019
MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement
S Donkervoort, R Sabouny, P Yun, et al.
JAMA Neurology
|
August 29, 2022
Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial
Michela Guglieri, Paula R Clemens, Seth J Perlman, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 265) with videos related to
Sort By:
Page
of 27
Neurology
|
August 28, 2019
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function
Eric P Hoffman, Benjamin D Schwartz, Laurel J Mengle-Gaw, et al.
Journal of Neuroimmunology
|
April 13, 2010
Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis
K C O'Connor, C Lopez-Amaya, D Gagne, et al.
Journal of Comparative Effectiveness Research
|
August 28, 2020
Meta-analyses of ataluren randomized controlled trials in nonsense mutation Duchenne muscular dystrophy
Craig Campbell, Richard J Barohn, Enrico Bertini, et al.
Pharmacological Research
|
September 17, 2018
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug
Laurie S Conklin, Jesse M Damsker, Eric P Hoffman, et al.
The Lancet. Neurology
|
April 5, 2011
Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study
Brenda Banwell, Amit Bar-Or, Douglas L Arnold, et al.
American Journal of Human Genetics
|
February 2, 2022
Bi-allelic variants in neuronal cell adhesion molecule cause a neurodevelopmental disorder characterized by developmental delay, hypotonia, neuropathy/spasticity
Alina Kurolap, Florian Kreuder, Claudia Gonzaga-Jauregui, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
June 5, 2020
A National Spinal Muscular Atrophy Registry for Real-World Evidence
Victoria L Hodgkinson, Maryam Oskoui, Joshua Lounsberry, et al.
Contemporary Clinical Trials
|
April 29, 2017
Developing standardized corticosteroid treatment for Duchenne muscular dystrophy
Michela Guglieri, Kate Bushby, Michael P McDermott, et al.
Acta Neuropathologica
|
August 30, 2019
MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement
S Donkervoort, R Sabouny, P Yun, et al.
JAMA Neurology
|
August 29, 2022
Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial
Michela Guglieri, Paula R Clemens, Seth J Perlman, et al.
Page
of 27